Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Ethics declarations Conflict of Interest The authors declare no competing interests
In a recent study published in the journal JAMA Network Open , researchers compared the risk of hematologic cancers in type 2 diabetes (T2D) patients treated with glucagon-like peptide 1 receptor agonists (GLP-1RAs)
Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial
Combining GLP-1R and GCGR agonists has emerged as a promising strategy to overcome these challenges
US$ 26.51
US$ 22.69
US$ 20.21
US$ 23.01
US$ 26.61
US$ 21.75
